Here's Why VKTX Stock Plummeted 18% on Wednesday [Yahoo! Finance]
Companies Like Viking Therapeutics (NASDAQ:VKTX) Can Afford To Invest In Growth [Yahoo! Finance]
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $102.00 price target on the stock.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX